SCHEMBL19257599

SCHEMBL19257599

CC(=O)C(C)NC(=O)CNC(=O)CCCCCN1C(=O)C=CC1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 7/20 0.48
PTGS2 P35354 7/20 0.48
MGLL Q99685 5/20 0.42
ALDH1A1 P00352 4/20 0.42
FAAH O00519 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
HTT P42858 3/20 0.42
HPGD P15428 3/20 0.42
HSP90AA1 P07900 1/20 0.42
TLR9 Q9NR96 1/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
PKM P14618 1/20 0.42
XBP1 P17861 1/20 0.42
MAPK1 P28482 1/20 0.42
RECQL P46063 1/20 0.42
RAB9A P51151 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
GPR35 Q9HC97 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22267883 0.87 PTGS1 (0.45) PTGS1PTGS2MGLLALDH1A1FAAH
SCHEMBL19708967 0.86 PTGS1 (0.49) PTGS1PTGS2MGLLALDH1A1FAAH
SCHEMBL18515923 0.84 PTGS1 (0.42) PTGS1PTGS2MGLLALDH1A1FAAH
SCHEMBL25965248 0.84 PTGS1 (0.42) PTGS1PTGS2MGLLALDH1A1FAAH
SCHEMBL21882943 0.83 PTGS1 (0.54) PTGS1PTGS2MGLLALDH1A1FAAH
SCHEMBL14968581 0.83 PTGS1 (0.57) PTGS1PTGS2MGLLALDH1A1FAAH
SCHEMBL25748817 0.82 PTGS1 (0.50) PTGS1PTGS2MGLLALDH1A1FAAH
SCHEMBL25748815 0.82 PTGS1 (0.50) PTGS1PTGS2MGLLALDH1A1FAAH
SCHEMBL24383401 0.82 PTGS1 (0.45) PTGS1PTGS2MGLLALDH1A1FAAH
SCHEMBL14962680 0.82 PTGS1 (0.53) PTGS1PTGS2MGLLALDH1A1FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10723727-B2 Tubulysin analogs and methods for their preparation PFIZER INC. (US) 2020-07-28 US disclosed
WO-2017134547-A1 TUBULYSIN ANALOGS AND METHODS FOR THEIR PREPARATION PFIZER INC. (US) 2017-08-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10723727-B2 Tubulysin analogs and methods for their preparation NGLY1, TEK, TEKT1 PTGS1 4670/4885PTGS2 4790/4885MGLL 4563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.